SQI Diagnostics to Announce Third Quarter 2015 Results

TORONTO, Aug. 10, 2015 /CNW/ - SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the three and nine months ended June 30, 2015, after market close on Tuesday, August 18, 2015.  President and CEO, Andrew Morris, along with Company management, will host a conference call on Wednesday August 19, 2015 at 10:00 a.m. ET to review financial results and discuss business developments for the period. 

 Conference Call Details:



Date:

 Wednesday, August 19, 2015

Time:

10:00 a.m. ET

Live Call:

1-888-231-8191 (Canada and the United States)

Conference ID:

10424532

Webcast:

http://event.on24.com/r.htm?e=1034082&s=1&k=D2C225C39387ECA5E07301C04BC71407

An archived copy of the conference call will be available for 90 days on the Company website at www.sqidiagnostics.com/about/investors  and also at http://event.on24.com/r.htm?e=1034082&s=1&k=D2C225C39387ECA5E07301C04BC71407.

Detailed financial statements and the management's discussion and analysis (MD&A) will also be made available on the Company website at www.sqidiagnostics.com and at www.sedar.com.

For more information, please contact:

Chief Executive Officer

Andrew Morris

416.674.9500 ext. 229

amorris@sqidiagnostics.com

Chief Financial Officer

Lennie Ryer

416.674.9500 ext. 241

lryer@sqidiagnostics.com

About SQI Diagnostics
SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality. For more information, please visit www.sqidiagnostics.com.

Forward-looking Statements
This press release contains certain words and statements, which may constitute "forward-looking statements" within the meaning of applicable securities laws. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties detailed in the Company's ongoing filings with the securities regulatory authorities, available to the public at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE SQI Diagnostics Inc.

For further information: Chief Executive Officer, Andrew Morris, 416.674.9500 ext. 229, amorris@sqidiagnostics.com; Chief Financial Officer, Lennie Ryer, 416.674.9500 ext. 241, lryer@sqidiagnostics.com

RELATED LINKS
www.sqidiagnsotics.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890